Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine

Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine

Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday…

Be the first to comment

Leave a Reply

Your email address will not be published.


*